GlassScriptPhysician profile
Cristine Mattis
NPI 1356583678
$6,633.24
in general payments reported to CMS, 2019-2025
41 companies · $948 in 2025
The $948 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,188 · 2022: $1,427 · 2023: $2,178 · 2024: $892 · 2025: $948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,490 · Travel and Lodging: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,490.41 |
| Travel and Lodging | $527.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $794.38 | 2023-2025 | Interstim |
| Antares Pharma, INC. | $722.97 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Astellas Pharma US INC | $721.88 | 2021-2023 | Myrbetriq, Veozah |
| Sumitomo Pharma America, INC. | $487.84 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $415.99 | 2021-2025 | Axonics, Ams 700, Lithovue |
| C. R. Bard, INC. & Subsidiaries | $326.42 | 2023-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Urogen Pharma, INC. | $302.18 | 2022-2025 | Jelmyto |
| Abbvie INC. | $300.29 | 2021-2024 | |
| Endo Pharmaceuticals INC. | $240.48 | 2021-2024 | Xiaflex, Aveed |
| Urovant Sciences INC | $233.80 | 2021-2022 | |
| Myovant Sciences INC. | $195.07 | 2021-2022 | |
| Rochester Medical Corporation | $159.25 | 2021-2022 | |
| Accord Healthcare, INC. | $152.00 | 2023-2024 | |
| Janssen Biotech, INC. | $144.34 | 2021-2025 | Erleada |
| Halozyme INC | $134.91 | 2023 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clarus Therapeutics INC. | $128.11 | 2021 | |
| Pfizer INC. | $106.28 | 2021-2025 | |
| Endo USA, INC. | $99.07 | 2024-2025 | Xiaflex, Aveed |
| Progenics Pharmaceuticals, INC. | $92.23 | 2022-2025 | |
| Coloplast Corp | $83.84 | 2023-2025 | Speedicath |
| Tolmar Pharmaceuticals, INC. | $82.29 | 2022 | |
| Teleflex LLC | $69.72 | 2021-2024 | Urolift |
| Axonics, INC. | $57.91 | 2021-2023 | Axonics |
| Smith+Nephew, INC. | $57.85 | 2021-2024 | Stravix Pl |
| Civco Medical Instruments | $54.34 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $53.38 | 2024-2025 | Adstiladrin |
| Verity Pharmaceuticals INC. | $50.89 | 2024-2025 | Trelstar, Tlando |
| Immunitybio, INC. | $47.52 | 2025 | |
| Merck Sharp & Dohme LLC | $45.38 | 2022 | |
| Convatec INC. | $42.40 | 2021-2022 | |
| Hollister Incorporated | $33.82 | 2022-2023 | Infyna Chic, Vapro, Onli |
| Procept Biorobotics Corporation | $31.65 | 2025 | |
| Blue Earth Diagnostics | $21.69 | 2021 | |
| Dendreon Pharmaceuticals LLC | $21.42 | 2021 | |
| Ambu INC. | $19.90 | 2025 | |
| Mission Pharmacal Company | $18.57 | 2023 | |
| 180 Medical, INC. | $18.48 | 2022 | |
| Travere Therapeutics, INC. | $17.84 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.48 | 2022 | |
| Olympus America INC. | $15.85 | 2025 | Itind System |
| Allergan, INC. | $14.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cristine Mattis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.